Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Familial juvenile hyperuricemic nephropathy type 2 is a rare autosomal dominantly inherited disease of childhood characterized by hypoproliferative anemia, hyperuricemia and slowly progressing kidney failure due to dysregulation of the renin-angiotensin system (RAS).
Features include: Renal hypoplasia, Tubulointerstitial fibrosis, Low red blood cell count (anemia), and Focal segmental glomerulosclerosis and 5 more.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Kidneys and urinary system | 7 | Renal hypoplasia, Tubulointerstitial fibrosis, Focal segmental glomerulosclerosis |
Blood and immune system | 1 | Low red blood cell count (anemia) |
Muscles | 1 | Renal tubular atrophy |
Age of onset: adolescence, childhood.
In the most comprehensive report of autosomal dominant tubulointerstitial kidney disease due to REN pathogenic variants (ADTKD-REN) to date, comprising 111 individuals from 30 families, observed two clinical presentations, childhood/adolescent onset and adult onset, which correlate with the protein domains encoded by REN variants . Childhood/adolescent onset, the more common presentation, is caused by REN variants encoding the signal peptide or prosegment domains. It is characterized by decreased estimated glomerular filtration rate (eGFR), acidosis, hyperkalemia, and anemia early in life, followed by slowly progressive chronic kidney disease and gout. Some children also experience polyuria. Adult onset, the less common presentation, is caused by REN variants encoding the mature renin peptide. It is characterized by gout or mild, slowly progressive CKD, beginning in the third decade. Anemia, hyperkalemia, and acidemia do not occur. Table 4. ADTKD-REN: Comparison of Phenotypes by Genotype and Select Features
Features | Childhood/Adolescent Onset | Adult Onset |
|---|---|---|
Signal peptide1 | Prosegment1 | Mature peptide2 |
# of families/persons | 21/69 | 4/27 |
Mean age at presentation ± SD |
REN function has not been fully characterized.
Familial juvenile hyperuricemic nephropathy type 2 is caused by mutations in the REN gene on chromosome 1.
Penetrance is age related. Thus, in individuals with childhood-onset disease, manifestations of ADTKD-REN, especially anemia, are evident early in life; and in individuals with adult-onset disease, manifestations (gout and chronic kidney disease) do not become evident until adulthood.
Source: GeneReviews — "Autosomal Dominant Tubulointerstitial Kidney Disease – REN"
Consensus clinical diagnostic criteria for autosomal dominant tubulointerstitial kidney disease due to REN pathogenic variants (ADTKD-REN) have been published (full text). Suggestive Findings ADTKD-REN should be suspected in individuals with the following clinical findings (grouped by age) and a family history consistent with autosomal dominant inheritance . Clinical Findings – Childhood/Adolescent-Onset Disease Low renin production (low to low-normal plasma renin and aldosterone levels associated with the following in most, but not all, individuals) manifesting as: • Blood pressure that is often borderline low, but usually asymptomatic • Hyperkalemia (serum potassium levels 5 mEq/L, sometimes as high as 6.5 mEq/L) in about 50% of individuals, often present from birth • Acidosis (serum bicarbonate levels between 15 and 24 mEq/L), often present from birth Hypoproliferative anemia in most affected children by age one year characterized by: • Low erythropoietin concentration • Low hemoglobin concentrations (usually 9-11 g/dL) • Low reticulocyte count relative to the hemoglobin concentration • Otherwise normal hematologic findings Hyperuricemia resulting from decreased renal excretion of uric acid: • Hyperuricemia (serum uric acid concentration 6 mg/dL) is present in 80% of affected individuals beginning in childhood. Usually, hyperuricemia in an individual with normal kidney function corresponds to a serum concentration of uric acid 1 SD above the normal value for age and sex. It is important to use age-related norms for serum urate . • Decreased fractional excretion of urinary uric acid in the vast majority of individuals with ADTKD-REN. See for reference ranges by age in individuals with normal kidney function. The fractional excretion of uric acid is usually 5% in adult men and 6% in adult women. The reduction of urate excretion can be detected in affected children with preserved renal function . Note: (1) The fractional excretion of urinary uric acid can be measured from a spot urine sample; however, a 24-hour urine collection is preferable. (2) Aspirin, diuretics, and nonsteroidal agents should be avoided during the collection. (3) Because the fractional excretion of uric acid rises above 5% as renal function worsens, this test is not sensitive in individuals who have an eGFR 70 mL/min. Table 1. Serum Uric Acid Concentration in Individuals with Normal Renal Function Age | Serum Concentration (mg/dL) Males | Females
5 yrs | 3.6±0.9 | 3.6±0.9 |
|---|---|---|
5-10 yrs | 4.1±1.0 | 4.1±1.0 |
12 yrs | 4.4±1.1 | 4.5±0.9 |
15 yrs | 5.6±1.1 | 4.5±0.9 |
18 yrs | 6.2±0.8 | 4.0±0.7 , , Table 2. |
Fractional Excretion of Urinary Uric Acid in Individuals with Normal Renal Function Age | Mean | Standard Deviation1 |
0-6 wks | 29.1% |
Source: GeneReviews — "Autosomal Dominant Tubulointerstitial Kidney Disease – REN"
See for a diagnostic algorithm for inherited kidney disease. Table 5. Monogenic Kidney Diseases in the Differential Diagnosis of ADTKD-REN
Gene(s) | Disorder | MOI | Renal Phenotype | Distinguishing Features of Disorder |
|---|---|---|---|---|
CEP290INVSIQCB1NPHP1NPHP3NPHP4TMEM67(19 genes1) | Isolated nephronophthisis (NPH) | AR | Tubulointerstitial kidney disease; often seen in childhood can be assoc w/anemia mild hypotension | Absence of affected family members in multiple generations; Anemia usually correlates w/level of kidney function (i.e., may not be present in childhood).; Severity of kidney failure is usually much greater (usually requiring dialysis in teens early 20s).; Hyperkalemia acidemia are not as pronounced. |
Genetic testing for REN is available. Testing is considered confirmatory for diagnosis.
No approved treatments are currently available for familial juvenile hyperuricemic nephropathy type 2. The disease remains an area of unmet medical need.
Consensus management guidelines for autosomal dominant tubulointerstitial kidney disease due to pathogenic variants in REN (ADTKD-REN) have been published (full text).
To establish the extent of disease and needs in an individual diagnosed with ADTKD-REN, the evaluations summarized (if not performed as part of the evaluation that led to the diagnosis) are recommended.
Table 6.
Recommended Evaluations Following Initial Diagnosis in Individuals with ADTKD-REN
System/Concern | Evaluation1
| • Hemoglobin level
In childhood/adolescent-onset ADTKD-REN: possibly erythropoietin level
| Serum bicarbonate (part of basic metabolic panel)
| Serum potassium (part of basic metabolic panel)
| Serum urate
| In childhood/adolescent-onset ADTKD-REN: plasma renin/aldosterone level
| In childhood/adolescent-onset ADTKD-REN:
Obtain history for enuresis excessive thirst or urination.
24-hr urine collection to quantify urine output
| Serum creatinine (part of basic metabolic panel)
Nephrology referral
| Eval by kidney ultrasound
| Eval by genetics professionals2 to inform affected persons re nature, MOI, implications of ADTKD-REN to facilitate medical personal decision making
MOI = mode of inheritance
1. Applies to both presentations of ADTKD-REN except where indicated
2. Medical geneticist, certified genetic counselor, or certified advanced genetic nurse
Source: GeneReviews — "Autosomal Dominant Tubulointerstitial Kidney Disease – REN"
Avoid use of the following:
NSAIDs, especially in a person who is dehydrated or in a febrile child, as they can precipitate acute renal failure . The use of other analgesics/antipyretics should be considered.
Angiotensin-converting enzyme inhibitors, which may not be beneficial in the treatment of CKD and could aggravate the underlying relative renin deficit
Drugs known to be nephrotoxic
The low-sodium diet typically prescribed in the treatment of CKD
Avoid the following, which may worsen hyperuricemia, leading to more frequent attacks of gout:
Volume depletion, dehydration, and physical exertion under extreme conditions (e.g., when it is hot)
High meat and seafood intake
Source: GeneReviews — "Autosomal Dominant Tubulointerstitial Kidney Disease – REN"
Search ClinicalTrials.gov in the US and EU Clinical Trials Register in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.
Source: GeneReviews — "Autosomal Dominant Tubulointerstitial Kidney Disease – REN"
View trials for familial juvenile hyperuricemic nephropathy type 2
Childhood/adolescent-onset disease. Monitor blood pressure, serum potassium, bicarbonate, creatinine, and hemoglobin at least every six months. Adult-onset disease. Monitor blood pressure, serum potassium, bicarbonate, creatinine, and hemoglobin every six to 12 months, depending on the level of kidney function.
Source: GeneReviews — "Autosomal Dominant Tubulointerstitial Kidney Disease – REN"
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for familial juvenile hyperuricemic nephropathy type 2.
6 publications have been identified in PubMed for familial juvenile hyperuricemic nephropathy type 2. Research spans Case Report / Case Series (50%), Review / Meta-Analysis (17%), and Basic Science / Preclinical (17%).
Shamam YM (2026). [PMID: 33760469](https://pubmed.ncbi.nlm.nih.gov/33760469/). *Unknown Journal*. [Review / Meta-Analysis]
Xu J (2025). [PMID: 41480152](https://pubmed.ncbi.nlm.nih.gov/41480152/). *Front Genet*. [Case Report / Case Series]
Li MS (2025). [PMID: 41143746](https://pubmed.ncbi.nlm.nih.gov/41143746/). *Nephrol Dial Transplant*. [Epidemiology / Natural History]
Niedbalska-Tarnowska J (2024). [PMID: 38520530](https://pubmed.ncbi.nlm.nih.gov/38520530/). *Pediatric nephrology (Berlin, Germany)*. [Basic Science / Preclinical]
Gonçalves F (2024). [PMID: 39216982](https://pubmed.ncbi.nlm.nih.gov/39216982/). *Nefrologia*. [Case Report / Case Series]
Ma J (2024). [PMID: 39722771](https://pubmed.ncbi.nlm.nih.gov/39722771/). *Front Pediatr*. [Case Report / Case Series]
Data assembled from 8 of 12 sources · Last updated Sep 19, 2026, 11:55 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
19.7±15.7 yrs
22.4±20.2 yrs |
Age atpresentation | 10 yrs | 39% |
10-20 yrs | 32% | 11% |
20 yrs | 29% | 28% |
Presentedwith: | AKI | 10% |
Anemia, acidosis, CKD | 13% | 0 |
Anemia | 31% | 50% |
CKD | 22% | 14% |
Gout | 25% | 36% |
Anemia as child | 91% | 69% |
Gout | 56% | 65% |
Age of first gout attack ± SD | 29.7±9.9 yrs | 25.7±8.2 yrs |
Age of ESKD ± SD | 53.1±10.6 yrs | 50.8±17.6 yrs |
Source: GeneReviews — "Autosomal Dominant Tubulointerstitial Kidney Disease – REN"
11.7
6 wks-1 yr | 23.9% | 10.4 |
1-3 yrs | 15.2% | 6.2 |
3-13 yrs | 12.2% | 5.5 |
13 yrs | Female | 8.0% |
Male | 10.3% | 4.2 The fractional excretion of urinary uric acid can be calculated as follows: urine uric acid concentration x serum creatinine concentration serum uric acid concentration x urine creatinine concentration 1. A fractional excretion of urate 1 SD below the mean suggests reduced urate excretion. |
COL4A5 | Alport syndrome ( other types of hereditary glomerulonephritis) | XLARAD | Microscopic hematuria (microhematuria), proteinuria, progression to ESKD | Frequent cochlear ocular manifestations; Hematuria is present.; Much more severe in males than in females DNAJB11 GANAB PKD1 |
PKD2 | Autosomal dominant polycystic kidney disease (ADPKD) | AD | Bland urinary sediment2; large # of cysts age 25 yrs | Numerous cysts seen on kidney ultrasound |
GLA | Fabry disease, classic form | XL | Proteinuria (usually than in ADTKD-UMOD); gradual deterioration of renal function to ESKD in ~3rd-5th decade3 | Classic form (males w/1% -Gal A activity) usually has onset in childhood or adolescence w/periodic crises of severe pain in extremities (acroparesthesias); vascular cutaneous lesions (angiokeratomas), hypohidrosis, characteristic corneal lenticular opacities. MUC1 |
ADTKD-MUC1 | AD | Minimal proteinuria; slowly progressive CKD | Only clinical findings are chronic kidney disease its sequelae.4 UMOD | — |
ADTKD-UMOD | AD | Proteinuria is rare; slowly progressive CKD | Not assoc w/anemia in childhood or acidemia hyperkalemia often seen in ADTKD-REN4 | — |
Phenotype is indistinguishable from adult-onset ADTKD-REN. DNAJB114 | Atypical ADPKD-ADTKD | AD | Slowly progressive CKD, multiple renal cysts | Numerous kidney cysts are common. |
HNF1B | ADTKD-HNF1B | AD | Variable other manifestations incl maturity-onset diabetes of the young, hyperuricemia gout, CKD, CAKUT, unexplained liver function abnormalities | Incomplete penetrance for characteristic renal involvement absence of other variable manifestations |
mtDNA | m.547AT5 | Mat | Chronic tubulointerstitial kidney disease | Absence of childhood anemia, hyperkalemia, acidemia PAX2 |
PAX2-related disorder | AD | Glomerular proteinuria, hematuria, CKD, ocular coloboma | Absence of hematuria, proteinuria, coloboma | — |
SEC61A1 | ADTKD-SEC61A1 | AD | Slowly progressive CKD, leukopenia, abscess formation, intrauterine postnatal growth restriction | Absence of leukopenia, abnormal growth -Gal A = alpha-galactosidase A; AD = autosomal dominant; AR = autosomal recess... |
Source: GeneReviews — "Autosomal Dominant Tubulointerstitial Kidney Disease – REN"